Gene · 684
Papers3,814
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,814
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular vesicles - on the cusp of a new language in the biological sciences. | Extracell Vesicles Circ Nucl Acids | 2023 | 38288044 | PubTator, text mining | PubMed |
| MEMMAL: A tool for expanding large-scale mechanistic models with machine learned associations and big datasets. | Front Syst Biol | 2023 | 38269333 | PubTator, text mining | PubMed |
| Peripheral immune responses to filoviruses in a reservoir versus spillover hosts reveal transcriptional correlates of disease. | Front Immunol | 2023 | 38259437 | PubTator, text mining | PubMed |
| Network pharmacology and experiment validation investigate the potential mechanism of triptolide in oral squamous cell carcinoma. | Front Pharmacol | 2023 | 38259290 | PubTator, text mining | PubMed |
| Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS. | Pathogens | 2023 | 38251321 | PubTator, text mining | PubMed |
| Impaired activation of plasmacytoid dendritic cells via toll-like receptor 7/9 and STING is mediated by melanoma-derived immunosuppressive cytokines and metabolic drift. | Front Immunol | 2023 | 38239354 | PubTator, text mining | PubMed |
| Leveraging technology-driven strategies to untangle omics big data: circumventing roadblocks in clinical facets of oral cancer. | Front Oncol | 2023 | 38234400 | PubTator, text mining | PubMed |
| CRISPR/Cas9 as a New Antiviral Strategy for Treating Hepatitis Viral Infections. | Int J Mol Sci | 2023 | 38203503 | PubTator, text mining | PubMed |
| Molecular biology of canine parainfluenza virus V protein and its potential applications in tumor immunotherapy. | Front Microbiol | 2023 | 38173672 | PubTator, text mining | PubMed |
| The DNA repair enzyme, aprataxin, plays a role in innate immune signaling. | Front Aging Neurosci | 2023 | 38161589 | PubTator, text mining | PubMed |
| Tetherin Restricts SARS-CoV-2 despite the Presence of Multiple Viral Antagonists. | Viruses | 2023 | 38140605 | PubTator, text mining | PubMed |
| An Inducible ESCRT-III Inhibition Tool to Control HIV-1 Budding. | Viruses | 2023 | 38140530 | PubTator, text mining | PubMed |
| ISGF3 and STAT2/IRF9 Control Basal and IFN-Induced Transcription through Genome-Wide Binding of Phosphorylated and Unphosphorylated Complexes to Common ISRE-Containing ISGs. | Int J Mol Sci | 2023 | 38139463 | PubTator, text mining | PubMed |
| UBE2O reduces the effectiveness of interferon-α via degradation of IFIT3 in hepatocellular carcinoma. | Cell Death Dis | 2023 | 38129382 | PubTator, text mining | PubMed |
| Autophagy as a dual-faced host response to viral infections. | Front Cell Infect Microbiol | 2023 | 38125906 | PubTator, text mining | PubMed |
| Single-cell sequencing highlights heterogeneity and malignant progression in actinic keratosis and cutaneous squamous cell carcinoma. | Elife | 2023 | 38099574 | PubTator, text mining | PubMed |
| Media matters: culture medium-dependent hypervariable phenotype of mesenchymal stromal cells. | Stem Cell Res Ther | 2023 | 38087388 | PubTator, text mining | PubMed |
| Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2. | Nat Commun | 2023 | 38086794 | PubTator, text mining | PubMed |
| The two-stage molecular scenery of SARS-CoV-2 infection with implications to disease severity: An in-silico quest. | Front Immunol | 2023 | 38077337 | PubTator, text mining | PubMed |
| Polypeptides inhibit HIV-1 replication by interfering viral Vpu-mediated tetherin degradation. | Infect Med (Beijing) | 2023 | 38073890 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/684/papers?page=11